Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

COR stock hub

COR trades against a final fair-value range of $342.15-$514.68, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

Read full analysis Valuation Archive

Fair value midpoint

$428

$342 - $515

Upside to midpoint

+63.9%

Based on latest report

Confidence

78/100

Data quality and model convergence

Market cap

$50.8B

NYSE

Our take

Research highlights

What our analysis says

Pulled from the latest published report. The full reasoning lives under /analysis.

Biggest opportunity

Bull case

The market is incorrectly penalizing Cencora for short-term working capital anomalies, masking the highly durable 23% ROIC.

Biggest risk

Severe Drug Pricing Intervention

Recommended action

Strong Buy

COR is rated Strong Buy at $260.93 versus the reconciled fair value midpoint of $427.57, implying +63.86% upside/downside. Confidence is separately disclosed at 78/100.

Market data

Live price

Current market quote for this ticker.

Current price

COR

In the news

Latest news · COR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Analysis map

Jump into the research surface

These links all point into /analysis/*, so a hub rollback leaves the report reader and legacy redirects live.

Forecast

Targets

Bull, base, and bear cases with expected-return framing.

Valuation

Models

Fair-value bridge, DCF, owner earnings, and peer multiples.

Sensitivity

Grid

Cost-of-equity and terminal-growth stress table.

Risks

Bear case

Kill scenarios, soft-pass flags, and downside catalysts.

Earnings

Decision tree

Next earnings setup and beat / inline / miss thresholds.

Position sizing

Checkpoints

Entry, exit, conviction, and quarterly monitoring rules.

Financials

History

Revenue, margins, cash flow, and balance-sheet context.

Peers

Comps

Relative valuation and profitability against the cohort.

Moat

Durability

Economic-profit evidence and competitive advantage risk.

Industry cycle

Context

Sector phase, capital cycle, and secular tailwinds.

Scorecard

Factors

Six-factor overlay and 9-category weighted scorecard.

Recommendation

Verdict

Final action, action steps, opportunity, and biggest risk.

Perspectives

Lenses

Growth, value, and income investor reads.

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.2

P25 12.3P50 18.4P75 33.1

Trailing P/E0

P25 14.9P50 23.2P75 38.5

ROE107.1

P25 -105.6P50 -46.5P75 -3.1

ROIC23.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Our take

Indicator catalog

All COR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

281

Groups with data

Currency

USD

Showing 281 of 281 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001140859
Company name	Cencora, Inc.
Country	United States
Country code	US
Cusip	03090BBJ8
Employees	51,000
Employees Change	5,000%
Employees Change Percent	10.87
Enterprise value	$63.7B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Distribution
Isin	US03073E1055
Last refreshed	2026-05-10
Market cap	$50.8B
Market cap category	Large-Cap
Price	$261
Price currency	USD
Rev Per Employee	6,444,706.24x
Sector	Healthcare
Sic	5122
Symbol	COR
Website	https://www.cencora.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.02%
EV Earnings	25x
EV Sales Forward	0.18x
EV/EBIT	14.95x
EV/EBITDA	12.02x
EV/FCF	40.89x
EV/Sales	0.19x
FCF yield	3.07%
Forward P/E	14.06x
P/B ratio	14.95x
P/E ratio	20x
P/S ratio	0.15x
PE Ratio10 Y	21.84x
PE Ratio3 Y	28.46x
PE Ratio5 Y	24.5x
PEG ratio	1.39x
PS Forward	0.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.3%
EBITDA Margin	1.61%
FCF margin	0.47%
Gross margin	3.8%
Gross Profit	$12.5B
Gross Profit Growth	22.5%
Gross Profit Growth Q	24.84%
Gross Profit Growth3 Y	14.13%
Gross Profit Growth5 Y	17.55%
Net Income	$2.5B
Net Income Growth	50.51%
Net Income Growth Q	128.64%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	16.38%
Pretax Margin	1.07%
Profit Margin	0.78%
Profit Per Employee	$49,974
Profitable Years	5
ROA	3.49
Roa5y	2.99
ROCE	16.7
ROE	107.1
ROIC	23.2
Roic5y	57.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.67%
Cagr15y	14.65%
Cagr1y	-13.68%
Cagr20y	14.79%
Cagr3y	16.85%
Cagr5y	17.9%
Div CAGR10	6.02%
Div CAGR3	7.06%
Div CAGR5	6.19%
EPS Growth	52.02
EPS Growth Q	128.3
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	18.86
FCF Growth	-56.42%
FCF Growth Q	-63.6%
FCF Growth3 Y	-13.97%
FCF Growth5 Y	3.95%
OCF Growth	-44.63%
OCF Growth Q	-60.06%
OCF Growth10 Y	-5.28%
OCF Growth3 Y	-7.89%
OCF Growth5 Y	6.51%
Revenue Growth	5.95x
Revenue Growth Q	3.85x
Revenue Growth Quarters	55x
Revenue Growth Years	13x
Revenue Growth3 Y	9.91x
Revenue Growth5 Y	10.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$4.3
Assets	$81.7B
Cash	$2.2B
Current Assets	$53.1B
Current Liabilities	$56.1B
Debt	$15.1B
Debt EBITDA	$2.66
Debt Equity	$4.21
Debt FCF	$9.69
Equity	$3.6B
Interest Coverage	8.99
Liabilities	$78.1B
Long Term Assets	$28.5B
Long Term Liabilities	$21.9B
Net Cash	$-12.9B
Net Cash By Market Cap	$-25.43
Net Debt EBITDA	$2.44
Net Debt Equity	$3.6
Net Debt FCF	$8.29
Tangible Book Value	$-19.1B
Tangible Book Value Per Share	$-98.22
WACC	6.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.95
Inventory Turnover	16.23
Net Working Capital	$-4.5B
Quick ratio	0.48
Working Capital	$-3B
Working Capital Turnover	$-67.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.91%
Dividend Growth	8.8%
Dividend Growth Years	21%
Dividend per share	$2.4
Dividend Years	26
Dividend Yield	0.92%
Ex Div Date	2026-05-15
Last Dividend	$0.6
Payout Frequency	Quarterly
Payout Ratio	18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	293.07%
1Y total return	-13.67%
200-day SMA	327.8
3Y total return	59.56%
50-day SMA	324.2
50-day SMA vs 200-day SMA	50under200
5Y total return	127.75%
All Time High	377.5
All Time High Change	-30.85%
All Time High Date	2025-11-25
All Time Low	2.47
All Time Low Change	10,474.32%
All Time Low Date	1995-08-09
ATR	11.16
Beta	0.65
Beta1y	0.04
Beta2y	0.07
Ch YTD	-22.7
High	266.4
High52	377.5
High52 Date	2025-11-25
High52ch	-30.85%
Low	254
Low52	244.8
Low52 Date	2026-05-06
Low52ch	6.64%
Ma50ch	-19.46%
Premarket Change Percent	0
Premarket Price	$256
Premarket Volume	277
Price vs 200-day SMA	-20.36%
RSI	24.23
RSI Monthly	45.91
RSI Weekly	27.37
Sharpe ratio	-0.45x
Sortino ratio	-0.38
Total Return	1.82%
Tr YTD	-22.57
Tr15y	677.26%
Tr1m	-18.64%
Tr1w	-14.12%
Tr3m	-27.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	2
Analyst Price Target Top	$406
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$4.74
Earnings EPS Estimate Growth	7.24
Earnings Revenue Estimate	80,983,286,264x
Earnings Revenue Estimate Growth	7.33x
Operating Income	$4.3B
Operating Income Growth	34.13
Operating Income Growth Q	34.49
Operating Income Growth3 Y	19.3
Operating Income Growth5 Y	12.65
Operating margin	1.3
Price target	$381
Price Target Change	$46.11
Price Target Change Top	$55.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	184,024,354%
Float Percent	94.58%
Net Borrowing	4,117,928,000
Shares Insiders	0.38%
Shares Institutions	96.23%
Shares Out	194,561,060
Shares Qo Q	0.03%
Shares Yo Y	-0.91%
Short Float	2.63%
Short Ratio	3.08
Short Shares	2.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.4B
Average Volume	1,910,081.1x
Bv Per Share	17.46
CAPEX	$-718M
Ch10y	241.2
Ch15y	529.6
Ch1m	-18.64
Ch1w	-14.12
Ch1y	-14.28
Ch20y	1,088.9
Ch3m	-27.33
Ch3y	55.41
Ch5y	116
Ch6m	-27.62
Change	2.12%
Change From Open	2.75
Close	255.7
Days Gap	-0.61
Depreciation Amortization	1,038,053,000
Dollar Volume	699,411,128.2
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$4.3B
EBITDA	$5.3B
EPS	$13.05
F Score	5
FCF	$1.6B
FCF EV Yield	2.45x
FCF Per Share	$8.01
Financing CF	3,553,473,000
Fiscal Year End	September
Founded	2,001
Goodwill	16,452,669,000
Graham Number	71.61569
Graham Upside	-72.57
Income Tax	$954.1M
Investing CF	-5,730,847,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2009-06-16
Last Split Type	Forward
Last10k Filing Date	2025-11-25
Lynch Fair Value	$214
Lynch Upside	-18.1
Ma150	338.9
Ma150ch	-22.97%
Ma20	304.7
Ma20ch	-14.32%
Net CF	57,696,000
Next Earnings Date	2026-08-05
Open	254.1
Optionable	Yes
P FCF Ratio	32.6
P OCF Ratio	22.32
Payment Date	2026-06-01
Position In Range	57.19
Post Close	261.1
Postmarket Change Percent	0.15
Postmarket Price	$261
Ppne	2,805,419,000
Pre Close	255.7
Price Date	2026-05-08
Price EBITDA	$9.58
Relative Volume	1.4x
Revenue	328,680,018,000x
SBC By Revenue	0.04x
Share Based Comp	143,183,000
Tax By Revenue	0.29x
Tax Rate	27.21%
Tr20y	1,476.71%
Tr6m	-27.38%
Us State	Pennsylvania
Volume	2,678,915
Z Score	4.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

9/10

Business quality stays separate from stock attractiveness.

Forward P/E

13.2x

Valuation uses the full report model stack, not a single multiple.

Next action

Strong Buy

Final action steps are kept in the recommendation tab.

Our take

Income

COR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$2.40 annual per share

Payout ratio

+18.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.2%

21 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2026-05-15

Performance

COR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns COR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+96.2%

Float: +94.6% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

COR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.2

Below 30: short-term oversold

Price vs 200-day MA

-20.4%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

-0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Peers

COR vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	4.3T	35.6x	9.5x	104.3%	+6.8%	+50.1%	Bán
ABNB	Airbnb Inc.	84B	34.7x	6.6x	15.9%	+29.9%	+14.9%	Giữ
ADBE	Adobe Inc.	102.3B	14.8x	4.2x	63.3%	+12.3%	-34.3%	Mua mạnh

Questions

About COR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current COR stock rating?

Cencora, Inc. is currently shown with Strong Buy in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full COR analysis?

The full report lives at /stocks/COR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for COR?

The latest report frames COR around $342 to $515. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the COR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.